Ayr Strategies Comments on Temporary Trading Disruption of “AYRSF” on OTC

TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, is aware of a temporary disruption of trading of its shares on the OTC under the symbol “AYRSF.” This disruption has been caused by an administrative issue at FINRA and the Company is working with the appropriate parties to correct the situation in order to resume trading as soon as possible. The Company’s shares continue to trade without disruption on the CSE under the ticker AYR.A.

Forward-Looking Statements

Certain information contained in this news release may be forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as “target”, “expect”, “anticipate”, “believe”, “foresee”, “could”, “would”, “estimate”, “goal”, “outlook”, “intend”, “plan”, “seek”, “will”, “may”, “tracking”, “pacing” and “should” and similar expressions or words suggesting future outcomes. This news release includes forward-looking information and statements pertaining to, among other things, Ayr’s future growth plans. Numerous risks and uncertainties could cause the actual events and results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to: anticipated strategic, operational and competitive benefits may not be realized; events or series of events, including in connection with COVID-19, may cause business interruptions; required regulatory approvals may not be obtained; acquisitions may not be able to be completed on satisfactory terms or at all; and Ayr may not be able to raise additional debt or equity capital. Among other things, Ayr has assumed that its businesses will operate as anticipated, that it will be able to complete acquisitions on reasonable terms, and that all required regulatory approvals will be obtained on satisfactory terms and within expected time frames. In particular, there can be no assurance that we will complete the pending acquisitions in or enter into agreements with respect to other acquisitions.

About Ayr Strategies Inc.

Ayr Strategies (“Ayr”) is an expanding vertically integrated, U.S. multi-state cannabis operator, focusing on high-growth markets. The Company cultivates and manufactures branded cannabis products for distribution through its network of retail outlets and through third-party stores. Ayr strives to enrich consumers’ experience every day – helping them to live their best lives, elevated.

Ayr’s leadership team brings proven expertise in growing successful businesses through disciplined operational and financial management, and is committed to driving positive impact for customers, employees and the communities they touch. For more information, please visit www.ayrstrategies.com.

Company Contact:

Megan Kulick, Head of Investor Relations
T: (646) 977-7914
Email: [email protected]

Investor
Relations Contact:

Sean Mansouri, CFA or Cody Slach
Gateway Investor Relations
T: (949) 574-3860
Email: [email protected]



Inphi Wins GSA’s Most Respected Public Semiconductor Company Award

Prestigious Industry Award Recognizes Inphi’s Remarkable Growth

SAN JOSE, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE) — Inphi Corporation (NASDAQ: IPHI), a leader in high-speed data movement interconnects, announced today that it was awarded the Global Semiconductor Alliance’s (GSA) award for Most Respected Public Semiconductor Company Achieving $500 Million to $1 Billion in Annual Sales. The award is based on feedback from the greater GSA community, and recognizes leading semiconductor companies that have exhibited market growth through technological innovation and exceptional business management strategies.

“Although it has been a challenging year for all, Inphi has become a major force in the semiconductor industry. Their peers, partners and customers admire their strong growth and accordingly the GSA has bestowed the ‘Most Respected Public Semiconductor Company Award’ to Inphi,” said Jodi Shelton, CEO and Co-Founder of GSA. “The company has had a rapid rise to the leading ranks of the high-speed data movement and accelerated the transition to the digital world. This recognition is well deserved.”

“Winning the GSA award culminates a tremendous 2020 for Inphi,” said Ford Tamer, President and CEO of Inphi. “This is very special for Inphi because it’s the first time we’ve been nominated and won the ‘Most Respected Public Semiconductor Award.’ Thank you to GSA and to our amazing Inphi team for your great accomplishments that have led to growing our revenue, profits, stock price, and market growth over 20 times since 2012. Thank you to our customers, partners, and shareholders for your continued support during the various ups and downs. We’re very honored.”

GSA member companies cast online votes each year for the Most Respected Public Semiconductor Companies at several revenue levels based on best products, vision and future opportunities. Over the past 24 years, the GSA awards program has recognized the achievements of top-performing semiconductor firms in a variety of categories.

About the GSA Awards Virtual Program

The annual GSA Awards Celebration is the industry’s premier event. Each year the GSA recognizes companies that have demonstrated excellence through their vision, strategy, execution and future opportunity. The celebration honors the achievements of semiconductor companies in several categories ranging from outstanding leadership to financial accomplishments, as well as overall respect within the industry. For a list of winners, please visit the event website.

About
Inphi

Inphi Corporation is a leader in high-speed data movement interconnects. We move big data – fast, throughout the globe, between data centers, and inside data centers.  Inphi’s expertise in signal integrity results in reliable data delivery, at high speeds, over a variety of distances. As data volumes ramp exponentially due to video streaming, social media, cloud-based services, and wireless infrastructure, the need for speed has never been greater. That’s where we come in. Customers rely on Inphi’s solutions to develop and build out the Service Provider and Cloud infrastructures, and data centers of tomorrow. To learn more about Inphi, visit www.inphi.com or connect with Inphi on Twitter or LinkedIn.

Inphi, the Inphi logo and Think fast are registered trademarks of Inphi Corporation. All other trademarks used herein are the property of their respective owners.

Corporate Contact:

Kim Markle
Inphi
[email protected]



Tauriga Sciences Inc. to Further Expand its Product Offerings With Dark Chocolate [20mg] CBD Infused Round Medallions

NEW YORK, NY, Dec. 04, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced the further expansion of its product offerings – with the development of dark chocolate [20mg] CBD Infused Round Medallions (“Medallions”).  Each dark chocolate medallion will be infused with 20mg CBD Isolate and will be sold exclusively on the Company’s E-Commerce website: www.taurigum.com. Additionally these dark chocolate medallions will be:  lab tested, kosher certified, cholesterol free, NON-GMO, THC Free, and Only 49 Calories per medallion.

Manufacturer’s Suggested Retail Price (“MSRP”):  $4.99 Each or $12.99 for Pack of 3 Medallions    

In other news, the Company is firmly on track to report record quarterly sales – for its current operating quarter (3rd Fiscal Quarter 2021 / Period: October 1, 2020 thru December 31, 2020).  Lastly, the Company is pleased with the initial sales of its Limited Edition Hanukkah Special Gift Pack (“Hanukkah Special”) and is expecting a sharp increase over the next 15-20 days.    

Link to Purchase Tauri-Gum™ Hanukkah Special Gift Pack:

Link:  https://taurigum.com/products/hannukah-gift-special

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives.  The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.   

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)

On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.

The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

DISCLAIMER — Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

555 Madison Avenue, 5th Floor

New York, NY  10022

Chief Executive Officer

Mr. Seth M. Shaw

Email: [email protected]

cell # (917) 796 9926

Instagram: @taurigum

Twitter: @SethMShaw

Corp. Website:  www.tauriga.com

E-Commerce Website:  www.taurigum.com

Attachment



Latest job numbers signal bleak winter ahead

OTTAWA, Dec. 04, 2020 (GLOBE NEWSWIRE) — Canada’s unions are raising the alarm that many workers are facing a bleak winter of unemployment and under-employment with no immediate relief in sight.

November’s labour force survey released today by Statistics Canada showed high rates of long-term unemployment. A total of 1.5 million people are currently unemployed and looking for work; 400,000 have been without work for six months or longer. Another 317,000 workers dropped out of the labour market altogether last month.

“The scale of the jobs crisis has been without parallel in recent memory,” said Hassan Yussuff, President of the Canadian Labour Congress. “The second wave of this pandemic is making life very difficult for many workers, many of whom have given up trying to find work for the time being. Beyond the immediate emergency supports that are helping to put food on the table for these families, government stimulus will be key to putting people back to work.”

The survey also showed that women continue to bear the brunt of child care responsibilities, with 55 per cent more mothers with young children working less than half their usual hours compared to this time last year.

The federal government has made commitments towards the creation of one million jobs and investments in skills and training.

“We’re heartened that the government has promised to make investments in long-term care and child care, two areas that employ significant numbers of women, including many who are racialized,” said Yussuff. “However, time is of the essence and workers need to see concrete actions.”

A recent study showed that investment in early learning and child care would create 200,000 new jobs in child care provision and another 80,000 indirect jobs, including 8,000 construction jobs. It would also increase women’s participation by as many as 725,000 additional workers.

Austerity policies implemented soon after the 2008-09 global economic downturn led to sluggish growth, prolonged unemployment and growing precarity in Canada. In our current crisis, continued income support and expanded public investments will be crucial to help people weather the pandemic’s second wave and to move the nation towards a strong recovery.

To arrange an interview, please contact:
CLC Media Relations
[email protected]
613-526-7426



DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Loop Industries, Inc. (LOOP)

PR Newswire

BENSALEM, Pa., Dec. 4, 2020 /PRNewswire/ — Law Offices of Howard G. Smith reminds investors of the upcoming December 14, 2020deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Loop Industries, Inc. (“Loop” or the “Company”) (NASDAQ: LOOP) securities between September 24, 2018 and October 12, 2020, inclusive (the “Class Period”).  

Investors suffering losses on their Loop investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected].

On October 13, 2020, Hindenburg Research published a report alleging, among other things, that “Loop’s scientists, under pressure from CEO Daniel Solomita, were tacitly encouraged to lie about the results of the company’s process internally.” The report also stated that “Loop’s previous claims of breaking PET down to its base chemicals at a recovery rate of 100% were ‘technically and industrially impossible,'” according to a former employee. Moreover, the report alleged that “Executives from a division of key partner Thyssenkrupp, who Loop entered into a ‘global alliance agreement’ with in December 2018, told us their partnership is on ‘indefinite’ hold and that Loop ‘underestimated’ both costs and complexities of its process.”

On this news, Loop’s share price fell $3.78, or over 32%, to close at $7.83 per share on October 13, 2020, thereby damaging investors.

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Loop scientists were encouraged to misrepresent the results of Loop’s purportedly proprietary process; (2) that Loop did not have the technology to break PET down to its base chemicals at a recovery rate of 100%; (3) that, as a result, the Company was unlikely to realize the purported benefits of Loop’s announced partnerships with Indorama and Thyssenkrupp; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you purchased Loop securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania, 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com

Cision View original content:http://www.prnewswire.com/news-releases/deadline-reminder-law-offices-of-howard-g-smith-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-against-loop-industries-inc-loop-301186366.html

SOURCE Law Offices of Howard G. Smith

Marvell Earns GSA’s Most Respected Public Semiconductor Company Award

PR Newswire

SANTA CLARA, Calif., Dec. 4, 2020 /PRNewswire/ — Marvell (NASDAQ: MRVL) has been named the “2020 Most Respected Public Semiconductor Company” by the Global Semiconductor Alliance (GSA) for companies with $1 billion to $5 billion in annual sales. Decided by GSA members, the Most Respected Public Semiconductor Company Awards are designed to identify public companies garnering the most respect within the semiconductor industry in terms of products, vision and future opportunities. Marvell also received this recognition in 2018.

“It is an honor for Marvell to be recognized by GSA. We have worked hard to create market leading products and technologies to propel the data infrastructure market together with our customers and partners,” said Matt Murphy, President and CEO of Marvell. “I couldn’t be more proud of the global Marvell team who have enabled our ongoing growth and transformation – particularly during the unprecedented challenges of 2020. Without their dedication and support, this win would not have been possible.”

GSA represents more than 250 of the top companies in the semiconductor industry – together, its members generate 75% of the industry’s revenues. The GSA Awards recognize the achievements of top semiconductor companies and the exemplary individuals who work at these companies.

“Marvell continues to make innovative strides within the semiconductor industry, expanding its portfolio of products to support the needs of key industries, making strategic acquisitions, and joining coalitions to further the advancement of industry standards,” said Jodi Shelton, CEO and Co-Founder of GSA. “GSA offers its congratulations to Marvell on its well-deserved win.”

About GSA
GSA is Where Leaders Meet to establish an efficient, profitable and sustainable high technology global ecosystem encompassing semiconductors, software, solutions, systems and services. A leading industry organization that represents more than 25 countries and 250 corporate members, including 100 public companies, GSA provides a unique, neutral platform for collaboration, where global executives interface and innovate with peers, partners and customers to accelerate industry growth and maximize return on invested and intellectual capital. Members of the GSA represent 70 percent of the $450B+ semiconductor industry and continue to grow.

About Marvell
To deliver the data infrastructure technology that connects the world, we’re building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world’s leading technology companies for 25 years, we move, store, process and secure the world’s data with semiconductor solutions designed for our customers’ current needs and future ambitions. Through a process of deep collaboration and transparency, we’re ultimately changing the way tomorrow’s enterprise, cloud, automotive, and carrier architectures transform—for the better.

Marvell and the M logo are trademarks of Marvell or its affiliates. Please visit www.marvell.com for a complete list of Marvell trademarks. Other names and brands may be claimed as the property of others.

For further information, contact:

Stacey Keegan

Vice President, Corporate Marketing
[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/marvell-earns-gsas-most-respected-public-semiconductor-company-award-301186618.html

SOURCE Marvell

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen, Inc. (BIIB)

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen, Inc. (BIIB)

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 12, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Biogen, Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) securities between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”).

If you suffered a loss on your Biogen investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/biogen-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Biogen develops therapies for treating neurological and neurodegenerative diseases. One of its product candidates is aducanumab (BIIB037), an investigational human monoclonal antibody studied for use as a treatment for early Alzheimer’s disease.

On October 22, 2019, the Company announced that it would seek regulatory approval from the U.S. Food and Drug Administration (“FDA”) for aducanumab “based on a new analysis, conducted by Biogen in consultation with the FDA, of a larger dataset from the Phase 3 clinical studies that were discontinued in March 2019 following a futility analysis.” According to Biogen, the new analysis “show[ed] that aducanumab is pharmacologically and clinically active as determined by dose-dependent effects in reducing brain amyloid and in reducing clinical decline as assessed by the pre-specified primary endpoint Clinical Dementia Rating-Sum of Boxes (CDR-SB).”

On November 6, 2020, Reuters reported that an FDA panel found it “cannot ignore unsuccessful trial data on Biogen Alzheimer’s drug.” The panel had also “voted that an earlier-stage study does not offer supportive evidence of Biogen’s application for the drug, aducanumab.”

On this news, the Company’s stock price fell $92.64 per share, or 28%, to close at $236.26 per share on November 9, 2020, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding aducanumab’s effectiveness; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Biogen securities during the Class Period, you may move the Court no later than January 12, 2021 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los Angeles

Charles Linehan, 310-201-9150 or 888-773-9224

[email protected]

www.glancylaw.com

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

New multimodal hub on the Welland Canal a major step forward for industry

Thorold, ON, Dec. 04, 2020 (GLOBE NEWSWIRE) — An innovative industrial site along the international Welland Canal invites companies to join a new complex destined to be a game-changer.

The Thorold Multimodal Hub, in the heart of Niagara, Canada, is offering more than 500,000 square feet of available indoor warehouse and 200-acre outdoor storage and material handling space, providing flexible solutions that can be configured to suit diverse industrial operations.

The Hub comprises space owned by HOPA Ports, as well as a 155-acre former paper mill; the latter is a massive facility purchased recently by Bioveld Canada Inc.. Bioveld specializes in the productive repurposing of brownfield and industrial sites. “As a single point of contact for communities and corporations looking for progressive, long-term solutions, we leverage our experience leading restorative development teams to provide long-term gains for the investors, partners, and communities we work with,” said Bioveld Canada’s Board Chair, David Townsend.

This new major regional facility will be managed by HOPA Ports, through its subsidiary Great Lakes Port Management. Available spaces within the Hub feature infrastructure to reduce transportation costs and boost efficiency, with integrated, multimodal connections for industrial tenants. It will also include on-site property management and development services provided by HOPA Ports’ experienced team.

This investment in Niagara by Bioveld Canada and HOPA Ports is a step towards a more efficient and integrated network of marine facilities in Ontario. “As Ontario positions itself for an economic recovery, and as the province’s population and congestion issues grow, it just makes sense for us to be making better use of Ontario’s industrial and multimodal transportation capacity,” said Ian Hamilton, President & CEO of HOPA Ports. “With all of its advantages, Niagara is a natural place to invest.” HOPA Ports already operates integrated port facilities in Hamilton and Oshawa, and is very optimistic about the contribution to economic development and sustainable operation that the Thorold Multimodal Hub can make.

The Thorold Multimodal Hub is the first concrete step in the Niagara Ports plan, which was agreed by HOPA Ports and Niagara civic stakeholders in September. Niagara Ports is a plan to create a corridor of multimodal industrial hubs along the Welland Canal in Niagara. Other hubs, in Port Colborne and Welland, are currently in conceptual stages.

Spaces Available

“This is a highly flexible, waterfront space that can accommodate a variety of industrial operators,” said Jeremy Dunn, Commercial Vice President with HOPA Ports. “Leases here will include indoor, outdoor, turnkey and develop-to-suit. Companies locating here will benefit from the proximity to the U.S. border, the availability of marine and rail, and strategic location in the Niagara-Hamilton-Toronto trade corridor.”

Available spaces include a central warehouse, several other warehousing sites, truck dock and bays, train shed and manufacturing shops, as well as a wood shop, auto shop and offices. Some spaces are turnkey while others can be customized. With such variety, and the ability to be flexible in creating dynamic workspace for businesses, endless opportunities exist for businesses to prosper in the new Thorold Multimodal Hub.

 

QUOTES

Mayor Terry Ugulini, City of Thorold
This is a great day for the City of Thorold, and the people of Niagara. The City of Thorold is uniquely positioned to be the engine of a new era in marine transportation in Ontario. This investment by Bioveld Canada is testament to that. Today’s event is the culmination of years of planning and coordination. This is a true example of progress, working with our neighbouring municipalities, HOPA the private sector and higher levels of government to create economic sustainability. 

Niagara has a strong history in marine, and we are well positioned to be a trade and logistics hub for the world given the Welland canal, which runs through the great City of Thorold and our partner cities. The efficient movement of goods has never been more important to domestic and global supply chains. As Mayor of the City of Thorold I know that we will put our best foot forward as we work toward creating the future, one that will solve complex global problems and give rise to new possibilities for our citizens and businesses. We welcome this investment and more to come!

Niagara Regional Chair, Jim Bradley
For years we have touted Niagara’s strategic location as one of its key assets and this announcement proves how we are taking full advantage of our geographic position in North America. As COVID-19 continues to hamper economic growth across the globe, it is important to seek out ways to diversify Niagara’s economy while developing our status as a key trade corridor. I am confident this project will be a key element in helping to attract more investment and industry to our region for years to come.

Vance Badawey, MP Niagara Centre and Chair, Standing Committee on Transport, Infrastructure and Communities
 
This Multimodal Hub in Thorold is just the first step in the establishment of the Niagara Ports Trade Corridor. By working together with our partners, such as HOPA and Bioveld, we are improving supply-chain efficiency and transportation logistics, strengthening our region to become an innovative, economic, transportation/logistics-based leader. With our close proximity to major markets and recently ratified trade agreements that elevates our economic population to 1.8 billion, Niagara contributes to the inseparable relationship between Canada’s international trade performance and the integrated economies with our trading partners.

Chris Bittle, MP, St. Catharines

Niagara has long touted our strength as a strategic geographical hub with multiple transportation avenues available to businesses and manufacturers. Today’s announcement demonstrates the real economic opportunities this strength presents. As Canada emerges from the COVID-19 pandemic, it is essential that our economic growth is sustainable. Marine, rail and road transportation networks, as well as our proximity to major markets, present businesses and manufacturers with a unique way to do business efficiently. The Multimodal Hub in Thorold brings all transportation options to the table in one location and presents an excellent case for investment in our community. The result will lead to a stronger, more diverse local economy.

__________________________

About Thorold Multimodal Hub:

The Thorold Multimodal Hub is a 200-acre multimodal industrial complex in Niagara, adjacent to the Welland Canal. Unique to Niagara, it features marine, rail and highway access, as well as over 500,000 square feet of indoor warehouse and outdoor storage space, which can be configured to a wide variety of industrial, cargo handling and ancillary operations. The Hub comprises space owned by HOPA Ports, as well as a 155-acre former paper mill; the massive facility was purchased recently by Bioveld Canada Inc.

About Great Lakes Port Management and HOPA Ports:

Great Lakes Port Management (GLPM) is the manager of the new Thorold Multimodal Hub and a wholly owned subsidiary of Hamilton Oshawa Port Authority (HOPA Ports). As an integrated port network, HOPA Ports offers port and marine assets on the Great Lakes. We are developing multimodal spaces, including in Niagara, to support Ontario’s industries and facilitate trade. By investing in high-quality infrastructure and prioritizing sustainability, we build prosperous working waterfronts in Ontario communities.

-30-

For more information, please contact Larissa Fenn, HOPA Ports:


[email protected]


Tel: 905-667-3292
Cell: 905-518-7632


www.hopaports.ca

More background on the Thorold Multimodal Hub and Niagara Ports.

Attachments



Larissa Fenn
HOPA Ports
905-667-3292
[email protected]

CareFirst BlueCross BlueShield Extends COVID-19 Benefits into 2021, Encourages Flu and Childhood Vaccinations

Health and safety of members and communities are paramount as cases surge nationally

Baltimore, Md./Washington, D.C., Dec. 04, 2020 (GLOBE NEWSWIRE) — Today, CareFirst BlueCross BlueShield (CareFirst) announced an additional extension of benefits for fully insured members to ensure the health and well-being of those it serves as the community and national spread of the coronavirus continue to accelerate. The benefits, which include the patient cost share waivers for the testing and treatment of COVID-19, were initially put in place last spring and set to expire on December 31, 2020, except as otherwise required by law. The benefits will be extended into 2021.

“With the surge of positive COVID-19 cases in our communities and neighborhoods, no one should worry or put off getting tested or treated for this virus because they are concerned about how they will pay for it,” said Brain D. Pieninck, President and CEO of CareFirst. “The strength and health of our communities rely on each of us doing our part by socially distancing and wearing a mask. Together, we can beat back this virus and start down the road to recovery. Right now, CareFirst is protecting the health of our members, communities, associates, and frontline healthcare workers by ensuring continued access to the testing and treatments needed to recover and heal fully.”

COVID-19 vaccines are expected to gain Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration this year and will also be a covered benefit at no cost for CareFirst members. CareFirst is committed to helping communities access the vaccine as quickly and easily as possible but cautions patience as each state finalizes vaccination plans.

In addition to the extensions announced today, CareFirst encouraged individuals to get a flu shot and keep up to date on the immunizations vital to their children’s health. “We encourage everyone to get the flu shot because it is another easy step we can all take to stay healthy, keep our neighbors well, and lessen the impact on an already strained healthcare system,” said Pieninck. “Vaccinations are a safe and critically important tool that support and build community health.”

CareFirst has taken numerous actions throughout the COVID-19 pandemic to support our members, providers, and communities. These include premium credits and rebates for individual, small and large group customers, premium deferrals, and relaxation of authorization and concurrent review criteria. CareFirst also provided accelerated payments to an array of healthcare providers experiencing financial strain and invested in community nonprofit organizations working to address complex and emerging health, social and economic needs.  In addition, CareFirst committed resources for personal protection equipment (PPE) to almost 200 federally qualified health centers and independent primary care providers and recently delivered care packages to vulnerable members and will continue to work within communities to ensure the health and safety of its members. 

Throughout the public health emergency, CareFirst will continue to work to identify barriers and solutions to ensure the whole health of the members, associates, and communities it serves.

About CareFirst BlueCross BlueShield

In its 83rd year of service, CareFirst, an independent licensee of the Blue Cross and Blue Shield Association, an association of independent, locally operated Blue Cross and Blue Shield companies, is a not-for-profit healthcare company which, through its affiliates and subsidiaries, offers a comprehensive portfolio of health insurance products and administrative services to 3.3 million individuals and employers in Maryland, the District of Columbia and Northern Virginia. In 2019, CareFirst invested $43 million to improve overall health, and increase the accessibility, affordability, safety and quality of healthcare throughout its market areas. To learn more about CareFirst BlueCross BlueShield, visit our website at www.carefirst.com or follow us on Facebook, Twitter, LinkedIn or Instagram



Media Relations
CareFirst BlueCross BlueShield
1-800-914-6397
[email protected]

INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – PNM, ELY, TNAV, NAV, EIDX

PR Newswire

NEW YORK, Dec. 4, 2020 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:


PNM Resources, Inc. (NYSE: PNM)

 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Avangrid, Inc. for $50.30 in cash per share. If you are a PNM Resources shareholder, click here to learn more about your rights and options.  


Callaway Golf Company (NYSE: ELY)

 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Topgolf Entertainment Group. Under the terms of the merger agreement, Callaway will issue approximately 90 million shares of common stock to Topgolf shareholders. If you are a Callaway shareholder, click here to learn more about your rights and options.


Telenav, Inc. (NASDAQ: TNAV)
 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to V99, Inc., a corporation led by HP Jin, Co-Founder, President, and Chief Executive Officer of Telenav, for $4.80 per share. If you are a Telenav shareholder, click here to learn more about your legal rights and options.


Navistar International Corporation (NYSE: NAV)
 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Traton SE for $44.50 per share in cash. If you are a Navistar shareholder, click here to learn more about your rights and options.


Eidos Therapeutics, Inc. (NASDAQ: EIDX)
 concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to BridgeBio Pharma, Inc.  Under the merger agreement, Eidos stockholders will receive either 1.85 shares of BridgeBio common stock or $73.26 in cash for each share of Eidos common stock owned. If you are an Eidos shareholder, click here to learn more about your rights and options. 

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected] 
[email protected]  
https://www.halpersadeh.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-reminds-shareholders-about-its-ongoing-merger-investigations-investors-are-encouraged-to-contact-the-firm–pnm-ely-tnav-nav-eidx-301186633.html

SOURCE Halper Sadeh LLP